Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability.
about
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.Neural stem cell transplantation promotes behavioral recovery in a photothrombosis stroke model.Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic ImmunosuppressionHuman Umbilical Tissue-Derived Cells Promote Synapse Formation and Neurite Outgrowth via Thrombospondin Family ProteinsTargeting the vasculature to improve neural progenitor transplant survivalQuantifications of in vivo labeled stem cells based on measurements of magnetic moments.Editorial: Stem cells and progenitor cells in ischemic stroke-fashion or future?Therapeutic Strategies for Leukodystrophic Disorders Resulting from Perinatal Asphyxia: Focus on Myelinating Oligodendrocytes.Neural differentiation of human Wharton's jelly-derived mesenchymal stem cells improves the recovery of neurological function after transplantation in ischemic stroke ratsPhase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke.Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury.Neural Stem Cell-Conditioned Medium Ameliorated Cerebral Ischemia-Reperfusion Injury in Rats.
P2860
Q30690412-421B351D-806D-4D9E-BD5D-09E0B85CD481Q36014178-CEF67436-E5D6-4E86-93FE-2D7848E4E79AQ36067866-0EB5B596-7059-4EC9-A415-9623C2697BC6Q36319845-29E2CA36-2635-467D-855B-896AB59B5882Q37074566-19E12D56-B6F6-43F4-920E-9D08CA219B02Q38378507-8B29C37B-93D4-4CDE-B3C1-9AFE633A5959Q38962945-B44F47C3-467D-4C66-ADE3-4E5F1D9E2896Q39404025-571B0F87-8D75-46C3-A1C8-A25D592EB4ACQ41429849-FA380C8B-24FC-4E90-BCDB-1A9D9C96094CQ41608195-FACBEB0B-7D4C-4F69-A41B-917371324FE4Q48562922-FCE7A849-96DD-4BE1-9FE2-C463F376D7AFQ55365149-0E2B0BA0-923B-4569-B55A-25E706F1C65C
P2860
Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Stem cell-based treatments aga ...... arding clinical applicability.
@ast
Stem cell-based treatments aga ...... arding clinical applicability.
@en
Stem cell-based treatments aga ...... arding clinical applicability.
@nl
type
label
Stem cell-based treatments aga ...... arding clinical applicability.
@ast
Stem cell-based treatments aga ...... arding clinical applicability.
@en
Stem cell-based treatments aga ...... arding clinical applicability.
@nl
prefLabel
Stem cell-based treatments aga ...... arding clinical applicability.
@ast
Stem cell-based treatments aga ...... arding clinical applicability.
@en
Stem cell-based treatments aga ...... arding clinical applicability.
@nl
P2860
P356
P1476
Stem cell-based treatments aga ...... arding clinical applicability.
@en
P2093
Dirk M Hermann
Thorsten R Doeppner
P2860
P356
10.3389/FNCEL.2014.00357
P577
2014-10-29T00:00:00Z